To include your compound in the COVID-19 Resource Center, submit it here.

Dropping your shorts

Most recent short interest data argue against imminent bubble in biotech

While some investors have begun to wonder out loud if there is a biotech bubble forming, the short interest numbers suggest the answer is "not yet" - although short interest in the larger biotechs is up over the past year.

Short interest for the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) ticked up 5% between Dec. 31 and Jan.

Read the full 591 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers